Preparation and characterization of monoclonal antibody against human B7-H4 molecule

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 33, Issue 4, 2014, Pages 270-274

  Zhang, Ning ^a   Fang, Peng ^a   Gu, Zong Jiang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5G3; UNCLASSIFIED DRUG; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; EPITOPE; VTCN1 PROTEIN, HUMAN;

A549 CELL LINE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG PROTEIN BINDING; FIBROBLAST; FLOW CYTOMETRY; IN VITRO STUDY; JURKAT CELL LINE; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; HYBRIDOMA; IMMUNOLOGY; METABOLISM;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL LINE; EPITOPES; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; JURKAT CELLS; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84907029351     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2013.0082     Document Type: Article

References (19)

1. Collins M, Ling V, and Carreno BM: The B7 family of immune-regulatory ligands. Genome Biol 2005;6:223.
2. Carreno BM, and Collins M: The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002;20:29-53.
3. Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, Chapoval AI, Flies DB, Bajorath J, and Chen L: B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003;18:849-861.
4. Prasad DV, Richards S, Mai XM, and Dong C: B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003;18:863-873.
5. Zang X, Loke P, Kim J, Murphy K, Waitz R, and Allison JP: B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA 2003;100: 10388-10392.
6. Choi IH, Zhu G, Sica GL, Strome SE, Cheville JC, Lau JS, Zhu Y, Flies DB, Tamada K, and Chen L: Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 2003;171: 4650-4654.
7. Yi KH, and Chen L: Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev 2009;229:145-151.
8. Arigami T, Uenosono Y, Hirata M, Hagihara T, Yanagita S, Ishigami S, and Natsugoe S: Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis. J Surg Oncol 2010;102:748-752.
9. Tringler B, Zhuo S, Pilkington G, Torkko KC, Singh M, Lucia MS Heinz DE, Papkoff J, and Shroyer KR: B7-H4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 2005;11:1842-1848.
10. Kryczed I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, and Zou W: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006;203:871-881.
11. Simon I, Zhuo S, Corral L, Diamandis EP, Sarno MJ, Wolfert RL, and Kim NW: B7-H4 is a novel membranebound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res 2006;66:1570-1575.
12. Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, and Shroyer KR: B7-H4 overexpression in ovarian tumors. Gynecol Oncol 2006;100:44-52.
13. Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, and Zou W: Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007;67:8900-8905.
14. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, and Wang X: B7-H3 and B7-H4 expression in non-smallcell lung cancer. Lung Cancer 2006;53:143-151.
15. Groth SF, and Scheidegger D: Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 1980;35: 1-21.
16. Mugler KC, Singh M, Tringler B, Torkko KC, Liu W, Papkoff J, and Shroyer KR: B7-H4 expression in a range of breast pathology: correlation with tumor T cell infiltration. Appl Immunohistochem Mol Morphol 2007;15:363-370.
17. Miyatake T, Tringler B, Liu W, Liu SH, Papkoff J, Enomoto T, Torkko KC, Dehn DL, Swisher A, and Shroyer KR: B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol 2007;106:119-127.
18. Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA, Scardino PT, Sharma P, and Allison JP: B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA 2007;104:19458-19463.
19. Wang X, Hao J, Metzger DL, Ao Z, Chen L, Ou D, Verchere CB, Mui A, and Warnock GL: B7-H4 Treatment of T cells inhibits ERK, JNK, p38, and AKT activation. PLoS One 2012;7:e28232.